Sanofi Wins Fees After Ditching 'Clearly Frivolous' FCA Suit
Amphastar Pharmaceuticals Inc. must pay Sanofi-Aventis' attorneys' fees for filing a "clearly frivolous" False Claims Act suit against the company's predecessor alleging the blood thinner Lovenox was improperly patented, as Amphastar...To view the full article, register now.
Already a subscriber? Click here to view full article